EFFICACY GUIDELINES
![ICH E1 Clinical Safety for Drugs used in Long-Term Treatment](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E1 Clinical Safety for Drugs used in Long-Term Treatment
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E2A - E2F Pharmacovigilance Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E2A - E2F Pharmacovigilance Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E7 Clinical Trials in Geriatric Population Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E7 Clinical Trials in Geriatric Population Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E8 General Considerations for Clinical Trials Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E8 General Considerations for Clinical Trials Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E9 Statistical Principles for Clinical Trials Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E9 Statistical Principles for Clinical Trials Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E10 Choice of Control Group in Clinical Trials Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E10 Choice of Control Group in Clinical Trials Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E11 - E11A Clinical Trials in Pediatric Population](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E11 - E11A Clinical Trials in Pediatric Population
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E12 Clinical Evaluation by Therapeutic Category Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E12 Clinical Evaluation by Therapeutic Category Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E14 Clinical Evaluation of QT Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E14 Clinical Evaluation of QT Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E15 Definitions in Pharmacogenetics | Pharmacogenomics](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E15 Definitions in Pharmacogenetics | Pharmacogenomics
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E16 Qualification of Genomic Biomarkers Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E16 Qualification of Genomic Biomarkers Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E17 Multi-Regional Clinical Trails Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E17 Multi-Regional Clinical Trails Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E19 Safety Data Collection Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E19 Safety Data Collection Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)
![ICH E20 Adaptive Clinical Trails Guidelines](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
EFFICACY GUIDELINES
Sathyanarayana M.Sc.
December 08, 2020
ICH E20 Adaptive Clinical Trails Guidelines
![Sathyanarayana M.Sc.](http://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjpEGiHgao13-NNSAw3snTKCiEIdXQk__fZFY4TBHQlFqmxBPNMiEkat4BC0LsUcOUeYx0q6ayORly_2NFM_7zjfJzDvz_R7bJ_ZTz51qyjZrc2DYH3_wX8Xfup2KXRdLw/w70/Logo.png)